Hypo-glycosylated follistatin-like 1 protein - Regencor
Alternative Names: EpicaPatch; hgFSTL-1 - Regencor; MyoBeads; rhFSTL1Latest Information Update: 28 Sep 2022
At a glance
- Originator Regencor
- Class Cardiovascular therapies; Glycoproteins; Proteins
- Mechanism of Action Cell proliferation modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cardiovascular disorders
Most Recent Events
- 28 Sep 2022 No recent reports of development identified for preclinical development in Cardiovascular-disorders in USA (Intra-arterial)